免疫核心

Manufacturing · Biological Products, (No Diagnostic Substances)

完成交易日收盘US$30.03+0.81%行情日期 2026-11-03 · 非实时

公开资料页汇总免疫核心（IMCR）的已发布行情、估值、风险、财务摘要与同业对比。行情截至2026-11-03，非实时；缺失值不按零处理。

股价走势

复权收盘价（美元）

2025-10-31 — 2026-11-03253 个交易日样本

查看交易日数据

2026-11-03IMCRUS$30.03

查看图表数据

日期	IMCR
2025-10-31	33.09
2025-11-03	32.38
2025-11-04	31.91
2025-11-05	30.8
2025-11-06	31.6
2025-11-07	33.5
2025-11-10	35
2025-11-11	35.2
2025-11-12	35.29
2025-11-13	35.37
2025-11-14	35.95
2025-11-17	36.57
2025-11-18	38.06
2025-11-19	38.65
2025-11-20	39.01
2025-11-21	39.35
2025-11-24	38.69
2025-11-25	39.87
2025-11-26	40.13
2025-11-28	39.5
2025-12-01	37.59
2025-12-02	36.17
2025-12-03	37.88
2025-12-04	40.22
2025-12-05	38.78
2025-12-08	38.11
2025-12-09	36.64
2025-12-10	36.03
2025-12-11	35.8
2025-12-12	36.8
2025-12-15	36.02
2025-12-16	36.21
2025-12-17	35.82
2025-12-18	35.9
2025-12-19	36.01
2025-12-22	35.98
2025-12-23	36.19
2025-12-24	36.57
2025-12-26	36.13
2025-12-29	35.36
2025-12-30	34.1
2025-12-31	34.71
2026-01-02	33.78
2026-01-05	32.75
2026-01-06	32.85
2026-01-07	33.76
2026-01-08	33.05
2026-01-09	33
2026-01-12	32.64
2026-01-13	32.3
2026-01-14	33.13
2026-01-15	32.75
2026-01-16	33.35
2026-01-20	33.33
2026-01-21	35.29
2026-01-22	35.03
2026-01-23	35.11
2026-01-26	35.06
2026-01-27	35.05
2026-01-28	33.13
2026-01-29	33
2026-01-30	32.55
2026-02-02	33.04
2026-02-03	32.07
2026-02-04	31.5
2026-02-05	30.92
2026-02-06	31.98
2026-02-09	33.26
2026-02-10	32.82
2026-02-11	32.93
2026-02-12	31.79
2026-02-13	32.28
2026-02-17	32.38
2026-02-18	32.51
2026-02-19	33.17
2026-02-20	32.68
2026-02-23	32.93
2026-02-24	33.68
2026-02-25	32.16
2026-02-26	32.04
2026-02-27	32.3
2026-03-02	32.67
2026-03-03	32.36
2026-03-04	33.73
2026-03-05	31.93
2026-03-06	32.94
2026-03-09	33.41
2026-03-10	33.34
2026-03-11	32.52
2026-03-12	31.04
2026-03-13	30.86
2026-03-16	30.57
2026-03-17	30.73
2026-03-18	30.04
2026-03-19	30.04
2026-03-20	29.91
2026-03-23	30.35
2026-03-24	29.95
2026-03-25	30.28
2026-03-26	30.51
2026-03-27	29.44
2026-03-30	29.29
2026-03-31	30.15
2026-04-01	30.31
2026-04-02	30.83
2026-04-06	31.94
2026-04-07	31.96
2026-04-08	31.85
2026-04-09	31.81
2026-04-10	31.05
2026-04-13	31.47
2026-04-14	31.69
2026-04-15	31.64
2026-04-16	31.38
2026-04-17	31.45
2026-04-20	31.46
2026-04-21	29.52
2026-04-22	29.98
2026-04-23	29.23
2026-04-24	29.3
2026-04-27	28.56
2026-04-28	28.79
2026-04-29	27.92
2026-04-30	27.91
2026-05-01	28.16
2026-05-04	28.52
2026-05-05	28.84
2026-05-06	30.73
2026-05-07	30.62
2026-05-08	29.58
2026-05-11	28.85
2026-05-12	29.3
2026-05-13	28.95
2026-05-14	28.76
2026-05-15	28.05
2026-05-18	28.37
2026-05-19	28.93
2026-05-20	29.54
2026-05-21	30
2026-05-22	28.83
2026-05-26	29.41
2026-05-27	28.52
2026-05-28	28.97
2026-05-29	28.89
2026-06-01	29.13
2026-06-02	29.56
2026-06-03	28.65
2026-06-04	28.76
2026-06-05	28.29
2026-06-08	27.79
2026-06-09	28.52
2026-06-10	27.9
2026-06-11	28.62
2026-06-12	28.96
2026-06-15	28.63
2026-06-16	28.17
2026-06-17	28.55
2026-06-18	28.6
2026-06-22	29.35
2026-06-23	29.2
2026-06-24	29.99
2026-06-25	30.54
2026-06-26	30.88
2026-06-29	30.42
2026-06-30	31.75
2026-07-01	31.65
2026-07-02	32.5
2026-07-06	31.94
2026-07-07	33.4
2026-07-08	33.78
2026-07-09	33.08
2026-07-10	31.95
2026-07-13	32.49
2026-07-14	33.47
2026-07-15	34.68
2026-07-16	34.47
2026-07-17	34.96
2026-07-20	34.05
2026-07-21	34.48
2026-07-22	35.54
2026-07-23	35.51
2026-07-24	35
2026-07-27	33.77
2026-07-28	33.51
2026-07-29	33.42
2026-07-30	33.87
2026-07-31	33.81
2026-08-03	32.43
2026-08-04	33.24
2026-08-05	33.29
2026-08-06	34.5
2026-08-07	34
2026-08-10	33.98
2026-08-11	34.18
2026-08-12	34.74
2026-08-13	34.2
2026-08-14	34.21
2026-08-17	35.05
2026-08-18	36.02
2026-08-19	36.86
2026-08-20	36.28
2026-08-21	36.88
2026-08-24	36.61
2026-08-25	37.4
2026-08-26	37.12
2026-08-27	36.75
2026-08-28	36.62
2026-08-31	36.32
2026-09-01	36.86
2026-09-02	37.37
2026-09-03	37.57
2026-09-04	36.13
2026-09-08	35.36
2026-09-09	34.47
2026-09-10	33.58
2026-09-11	32.6
2026-09-14	32.46
2026-09-15	31.78
2026-09-16	31.59
2026-09-17	32.3
2026-09-18	32
2026-09-21	32.18
2026-09-22	32.42
2026-09-23	31.54
2026-09-24	31.29
2026-09-25	30.72
2026-09-28	30.64
2026-09-29	30.85
2026-09-30	30.29
2026-10-01	30.54
2026-10-02	29.71
2026-10-05	29.59
2026-10-06	29.55
2026-10-07	29.41
2026-10-08	29.09
2026-10-09	29.39
2026-10-12	29.04
2026-10-13	27.82
2026-10-14	28.34
2026-10-15	29.48
2026-10-16	29.4
2026-10-19	29.84
2026-10-20	32.6
2026-10-21	32.09
2026-10-22	32.12
2026-10-23	30.98
2026-10-26	31.28
2026-10-27	31.96
2026-10-28	32.61
2026-10-29	31.27
2026-10-30	30.49
2026-11-02	29.79
2026-11-03	30.03

1、3、6、12个月分别按21、63、126、252个交易日取区间；缺失日期不从区间外补齐。

使用已有每日复权收盘样本，非实时行情；图中价格可能与未复权收盘报价不同。

01 · MARKET FRAME

行情、估值与风险

基于已完成交易日和已发布财务资料

市值US$1.5B

市盈率（TTM）—

自由现金流收益率-1%

距52周高点-25.3%

近一年波动率+36.8%

近一年最大回撤-30.9%

区间涨跌幅

10日-7.9%起点 2026-10-20

30日-7.4%起点 2026-09-22

90日-2.8%起点 2026-06-26

180日-7.3%起点 2026-02-17

250日-5.9%起点 2025-11-04

区间涨跌幅使用复权收盘价；估值和风险指标缺失时显示为—，不按零处理。

02 · FINANCIAL TRACE

财务摘要

公开页仅显示最近3个已校验报告期

年度财务走势

百万美元 · 年度报告期

查看报告期数据

2025-12-31营收400百万美元

指标	2026-07-31	2026-06-30	2025-12-31	2025-07-31	2025-06-30	2024-12-31	2024-07-31	2024-06-30	2023-12-31
营收	—	—	400	—	—	310.2	—	—	249.4
净利润	—	—	-35.5	—	—	-51.1	—	—	-55.3
自由现金流	—	—	-15.1	—	—	20.9	—	—	-2.5
股份数	51.5	—	—	50.4	—	—	50	—	—
债务	—	—	—	—	—	—	—	—	—
总资产	—	1,119.4	—	—	1,082.4	—	—	1,023.4	—

客户合同口径 · 营收采用客户合同口径，可能不等同于公司全部收入。

金额及股份数均以百万为单位。缺失或待核验数据不按零处理。

03 · PEER SET

同业对比

同一细分行业中市值最接近的公司

公司	市值	近250日涨跌幅	市盈率	距52周高点	波动率
NVAX诺瓦瓦克斯医药	US$1.6B	+28.9%	—	-24.5%	+70.9%
ALVOAlvotech	US$1.8B	-6%	—	—	—
MAZEMaze治疗	US$1.8B	-0.5%	—	-37.8%	+67.4%
VIR维尔生物技术	US$1.9B	+113.7%	—	-6%	+64.1%

同业由已覆盖公司的行业分类和市值接近度确定，仅用于横向研究；缺失数据不按零处理。